# Synthesis: Oxidative Stress Upstream of TDP-43 in ALS
## Summary of Debate
The theorist proposes a unidirectional model where mitochondrial ROS drives TDP-43 oxidation and nuclear export, with NRF2 dysfunction as a key amplifier. The skeptic counters with bidirectional causality evidence (Chung et al., 2020; Fang et al., 2022) showing TDP-43 loss-of-function disrupts mitochondrial gene expression, potentially creating the oxidative stress observed upstream. Clinical trial failures with antioxidants represent the most direct challenge to the upstream hypothesis.
## Scoring
| Criterion | Score | Rationale |
|-----------|-------|-----------|
| Mechanistic plausibility | 0.45 | Bidirectional causality is the fatal flaw—TDP-43 dysfunction causes mitochondrial impairment (Chung 2020; Fang 2022), undermining unidirectional ordering |
| Experimental tractability | 0.70 | Cross-genetic experiments (SOD1^G93A × TDP-43 knockdown) and TDP-43 mutant iPSC rescue with NRF2 activators are technically feasible |
| Clinical/translational relevance | 0.40 | Antioxidant trials repeatedly fail (CoQ10, vitamin E, selegiline); edaravone shows marginal benefit (PMCID: PMC6419469) |
| Evidence quality | 0.55 | Heavily SOD1-weighted; sporadic ALS and non-SOD1 genetic forms remain underexplored |
| Novelty | 0.40 | Conceptually established; not a novel framework |
| **Overall** | **0.50** | |
## Verdict: PARTIALLY_SUPPORTED
Oxidative stress contributes to ALS pathogenesis and can oxidatively modify TDP-43, but the bidirectional causality problem remains unresolved—evidence that TDP-43 loss-of-function itself causes mitochondrial dysfunction (Fang et al., 2022) means oxidative stress may be downstream rather than upstream. The systematic failure of antioxidant interventions in clinical trials is the most parsimonious evidence against oxidative stress as a primary upstream driver in human ALS.
**Key gap:** Temporal dissection experiments separating initiation from propagation in non-SOD1 models are required before upstream targeting can be validated as a therapeutic strategy.